Stock URGN UROGEN PHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart UroGen Pharma Ltd.

Equities

URGN

IL0011407140

Market Closed - Nasdaq
Other stock markets
 21:00:00 07/06/2024 BST 		5-day change 1st Jan Change
13.21 USD +0.15% Intraday chart for UroGen Pharma Ltd. -0.68% -11.93%
06-03 UroGen Pharma Appoints David Lin as New Chief Commercial Officer CI
05-14 Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
UROGEN PHARMA LTD. Stock UroGen Pharma Ltd.
 477M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 108B
BIONTECH SE Stock BioNTech SE
 24.57B -
ARGENX SE Stock argenx SE
 22.82B -
GENMAB A/S Stock Genmab A/S
 18.19B
  1. Stock Market
  2. Equities
  3. URGN Stock
  4. Charts UroGen Pharma Ltd.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW